[go: up one dir, main page]

ES2044944T3 - Hexahidroarilquinolizinas sustituidas. - Google Patents

Hexahidroarilquinolizinas sustituidas.

Info

Publication number
ES2044944T3
ES2044944T3 ES87307541T ES87307541T ES2044944T3 ES 2044944 T3 ES2044944 T3 ES 2044944T3 ES 87307541 T ES87307541 T ES 87307541T ES 87307541 T ES87307541 T ES 87307541T ES 2044944 T3 ES2044944 T3 ES 2044944T3
Authority
ES
Spain
Prior art keywords
substituted
hexahidroarilquinolizinas
disorders
certain
hexahydroarylkynolizines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87307541T
Other languages
English (en)
Inventor
John J Baldwin
Joseph P Vacca
Joel R Huff
J Mark Wiggins
Solms S Jane De
Steven D Young
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Application granted granted Critical
Publication of ES2044944T3 publication Critical patent/ES2044944T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/20—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed systems contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

CIERTAS HEXAHIDROARILQUINOLIZINAS SUSTITUIDAS Y SALES DE LA MISMA FARMACEUTICAMENTE ACEPTABLES SON ALFA2-ADRENOCEPTORES ANTAGONISTAS PERIFERIAMENTE SELECTIVOS. LOS COMPUESTOS SON ADAPTADOS PARA SER EMPLEADOS PARA EL TRATAMIENTO DE CIERTOS DESORDENES PATOLOGICOS, COMO HIPERTENSION, DIABETES, DESORDENES QUE ACARREAN AGREGACION DE PLAQUETAS, Y SIMILARES SIN EFECTOS LATERALES ATRIBUIDOS A UN EFECTO EN EL SISTEMA NERVIOSO CENTRAL.
ES87307541T 1986-08-28 1987-08-26 Hexahidroarilquinolizinas sustituidas. Expired - Lifetime ES2044944T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US90148586A 1986-08-28 1986-08-28

Publications (1)

Publication Number Publication Date
ES2044944T3 true ES2044944T3 (es) 1994-01-16

Family

ID=25414273

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87307541T Expired - Lifetime ES2044944T3 (es) 1986-08-28 1987-08-26 Hexahidroarilquinolizinas sustituidas.

Country Status (14)

Country Link
EP (1) EP0259092B1 (es)
JP (1) JP2582799B2 (es)
KR (1) KR880002869A (es)
AT (1) ATE78482T1 (es)
AU (1) AU597412B2 (es)
CA (1) CA1288435C (es)
DE (1) DE3780542T2 (es)
DK (1) DK447387A (es)
ES (1) ES2044944T3 (es)
GR (1) GR3005537T3 (es)
IL (1) IL83586A (es)
NZ (1) NZ221485A (es)
PT (1) PT85593B (es)
ZA (1) ZA876400B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4942235A (en) * 1989-03-16 1990-07-17 Merck & Co., Inc. Process for certain (2R-trans)hexahydroaroquinolizines
US5229387A (en) * 1991-09-20 1993-07-20 Syntex (U.S.A.) Inc. Decahydro-8H-isoquino[2,1-g][1,6]naphthyridine and decahydrobenzo[a]pyrrolo [2,3-e]quinolizine derivatives
FR2744451B1 (fr) * 1996-02-01 1998-04-24 Pf Medicament Nouvelles imidazolidinones, pyrimidinones, et 1,3-diazepin-2 -ones, leur preparation et leurs applications en therapeutique
US6141745A (en) * 1998-04-30 2000-10-31 Advanced Micro Devices, Inc. Functional bit identifying a prefix byte via a particular state regardless of type of instruction
FI126838B (en) 2014-12-16 2017-06-15 Vetcare Oy Process for the preparation of spirocyclic substituted benzofuroquinolizines
FI131529B1 (en) 2024-01-16 2025-06-11 Vetcare Oy Process for the racemization of benzofuroquinolizines

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1435573A (en) * 1973-05-25 1976-05-12 Wyeth John & Brother Ltd Indoloquinolizines
GB2106909B (en) * 1981-10-07 1984-09-19 Wyeth John & Brother Ltd Benzoquinolizines
IE57014B1 (en) * 1983-03-25 1992-03-11 Wyeth John & Brother Ltd Benzoquinolizines
GR850211B (es) * 1984-02-02 1985-05-24 Merck & Co Inc
NZ216283A (en) * 1985-06-03 1989-10-27 Merck & Co Inc Hexahydro arylquinolizine derivatives and pharmaceutical compositions

Also Published As

Publication number Publication date
AU597412B2 (en) 1990-05-31
GR3005537T3 (es) 1993-06-07
ZA876400B (en) 1988-02-25
KR880002869A (ko) 1988-05-12
DE3780542T2 (de) 1993-01-07
JPS63139183A (ja) 1988-06-10
EP0259092B1 (en) 1992-07-22
EP0259092A1 (en) 1988-03-09
DE3780542D1 (en) 1992-08-27
DK447387D0 (da) 1987-08-27
NZ221485A (en) 1991-04-26
CA1288435C (en) 1991-09-03
AU7720587A (en) 1988-03-03
ATE78482T1 (de) 1992-08-15
DK447387A (da) 1988-02-29
JP2582799B2 (ja) 1997-02-19
PT85593A (en) 1987-09-01
IL83586A0 (en) 1988-01-31
IL83586A (en) 1991-12-15
PT85593B (pt) 1990-05-31

Similar Documents

Publication Publication Date Title
ES2074867T3 (es) Derivados de quinazolina para potenciar la actividad antitumoral.
ES2132105T3 (es) 2-aminometil-cromanos como principios activos en farmacos para el tratamiento de enfermedades del sistema nervioso central.
ES2153357T3 (es) Uso de analogos nicotinicos para el tratamiento de enfermedades degenerativas del sistema nervioso.
NO924546L (no) Nye azaheterocyklylmetyl-kromaner
ES2071484T3 (es) Derivados de 2,4-diaminoquinazolinas para aumentar la actividad antitumoral.
MX9301348A (es) Nuevos compuestos que tienen actividad farmacologica, proceso para su preparacion y composicion farmaceutica que los comprende.
ECSP941122A (es) Derivados de 5-arilindoles
MX9303597A (es) Derivados de imidazopirinas, procedimiento para su preparacion preparaciones farmaceuticas que los contienen.
ES2044944T3 (es) Hexahidroarilquinolizinas sustituidas.
PE20020411A1 (es) Compuestos derivados de la triptamina y sus analogos que interactuan con el sistema melatoninergico
AR211006A1 (es) Procedimiento para preparar nuevos derivados de la 2-hidroxi-4-flourobutiprofenona depresores del sistema nervioso central.
ES2004218A6 (es) Procedimiento para preparar derivados de purina
ES551376A0 (es) Procedimiento para la obtencion de derivados de tetrahidroquinolina-1-ilcarbonilimidazol. (como desglose y con prioridad de la patente espanola no. 542.421, presentada el 19 de abril de 1.985).
ES2125879T3 (es) Triazaespirodecanona-metilcromanos para el tratamiento de enfermedades del sistema nervioso central.
ES2081834T3 (es) Pirrolidin-2-onas 4-metil y 4-etil sustituidas.
ES2000170A6 (es) Procedimiento para preparar 5,11-dihidro-6h-pirido(2,3-b)(1,4)-benzodiazepin-6-onas substituidas en posicion 11
ES2029791T3 (es) Un procedimiento para la preparacion de derivados de pirazina.
ES8104199A1 (es) Procedimiento de preparacion de nuevos derivados de benzoil-2 nitro-4 anilidas y sus sales
ES2031816T3 (es) Derivados triciclicos de la piridona.
ES2018807B3 (es) Procedimiento para curtir el cuero
ES2055440T3 (es) Derivados del acido quinurenico, su preparacion y composiciones farmaceuticas que los contienen.
ES520843A0 (es) Procedimiento para la obtencion de nuevos derivados del indolizino (8,7-b 7-indol.
ES2039290T3 (es) Procedimiento para preparar nuevos esteres aralquilicos.
SU542598A1 (ru) Устройство дл обработки резьбовых отверстий
SE422054B (sv) Sett att frmastella acetoximderivat att anvenda som lungnande medel, tymoabaleptika, antikonvulsiva medel, muskelavslappande medel och sedativa medel for det centrala nervsystemet

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 259092

Country of ref document: ES